Log on / register
Feedback | Support | My details
Open AccessHighly AccessResearch article

Metabolic Syndrome as a Cardiovascular Disease Risk Factor: Patients Evaluated in Primary Care

Joan-Josep Cabré1 email, Francisco Martín1 email, Bernardo Costa2 email, Josep L Piñol6 email, Josep L Llor3 email, Yolanda Ortega4 email, Josep Basora6 email, Marta Baldrich1 email, Rosa Solà7 email, Jordi Daniel6 email, Josep Ma Hernández1 email, Judit Saumell4 email, Jordi Bladé6 email, Ramon Sagarra1 email, Teresa Basora6 email, Dolors Montañés1 email, Joan L Frigola1 email, Angel Donado-Mazarrón2 email, Maria Teresa García-Vidal4 email, Isabel Sánchez-Oro2 email, Josep M de Magriñà4 email, Ana Urbaneja5 email, Francisco Barrio2 email, Jesús Vizcaíno1 email, Josep M Sabaté1 email, Irene Pascual1 email and Vanesa Revuelta1 email

1ABS Reus-1, Camí de Riudoms, 53–55, 43202 Reus, Spain

2ABS Reus-2, Camí de Riudoms 53–55, 43202 Reus, Spain

3ABS Deltebre, Avinguda Esportiva, 164, 43580 Deltebre, Spain

4ABS Reus-4, General Moragues 52, 43201 Reus, Spain

5ABS Reus-3, General Moragues 52, 43201 Reus, Spain

6Reus-Altebrat Primary Care Service, Spain

7Medicine Faculty, Rovira i Virgili University, Sant Llorenç 11, 43202 Reus, Spain

author email corresponding author email

BMC Public Health 2008, 8:251doi:10.1186/1471-2458-8-251

Published: 22 July 2008

Abstract

To estimate the prevalence of metabolic syndrome (MS) in a population receiving attention in primary care centers (PCC) we selected a random cohort of ostensibly normal subjects from the registers of 5 basic-health area (BHA) PCC. Diagnosis of MS was with the WHO, NCEP and IDF criteria. Variables recorded were: socio-demographic data, CVD risk factors including lipids, obesity, diabetes, blood pressure and smoking habit and a glucose tolerance test outcome. Of the 720 individuals selected (age 60.3 ± 11.5 years), 431 were female, 352 hypertensive, 142 diabetic, 233 pre-diabetic, 285 obese, 209 dyslipemic and 106 smokers. CVD risk according to the Framingham and REGICOR calculation was 13.8 ± 10% and 8.8 ± 9.8%, respectively. Using the WHO, NCEP and IDF criteria, MS was diagnosed in 166, 210 and 252 subjects, respectively and the relative risk of CVD complications in MS subjects was 2.56. Logistic regression analysis indicated that the MS components (WHO set), the MS components (IDF set) and the female gender had an increased odds ratio for CVD of 3.48 (95CI%: 2.26–5.37), 2.28 (95%CI: 1.84–4.90) and 2.26 (95%CI: 1.48–3.47), respectively. We conclude that MS and concomitant CVD risk is high in ostensibly normal population attending primary care clinics, and this would necessarily impinge on resource allocation in primary care.


© 1999-2008 BioMed Central Ltd unless otherwise stated